Submission Details
| 510(k) Number | K031604 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 22, 2003 |
| Decision Date | September 22, 2003 |
| Days to Decision | 123 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K031604 is an FDA 510(k) clearance for the GLYCOMARK, a Assay, 1,5-anhydroglucitol (15ag) (Class II — Special Controls, product code NOZ), submitted by Tomen America, Inc. (New York, US). The FDA issued a Cleared decision on September 22, 2003, 123 days after receiving the submission on May 22, 2003. This device falls under the Chemistry review panel. Regulated under 21 CFR 864.7470.
| 510(k) Number | K031604 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 22, 2003 |
| Decision Date | September 22, 2003 |
| Days to Decision | 123 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | NOZ — Assay, 1,5-anhydroglucitol (15ag) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.7470 |
| Definition | The Test Provides Quantitative Measurement Of 1,5-anhydroglucitol (15ag) In Patient's Blood. The Test Is For Professional Use, And Is Indicated For The Monitoring Of Glycemic Control In People With Diabetes. |